What is Ypsomed Holding AG?
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally.
0QLQ · Verdict
Solid reward · moderate risk
0QLQ stands out on cash flow and profitability, but watch the valuation signal.
Based on 88% data coverage
0QLQ · Verdict
2% free-cash-flow margin
30% net margin · 31% ROE
Above average
Below average
Model-based scoring. For information only — not financial advice.
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services. The company is listed on the LSE in UK, with a market capitalisation of 3.53B, and a P/E ratio of 2.2x.
The scoring profile indicates moderate reward potential, with profitability and growth as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.